{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:21:21Z","timestamp":1778541681586,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jpba.2023.115615","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T21:10:04Z","timestamp":1690837804000},"page":"115615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Implementing reversed-phase and hydrophilic interaction liquid chromatography into the characterization of DTPA-ramucirumab conjugate before radiolabeling"],"prefix":"10.1016","volume":"235","author":[{"given":"Denis K.","family":"Naplekov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-5658","authenticated-orcid":false,"given":"Pavel","family":"B\u00e1rta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franti\u0161ek","family":"Trejtnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Sklen\u00e1\u0159ov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Len\u010do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpba.2023.115615_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/19420862.2017.1412025","article-title":"Challenges and new frontiers in analytical characterization of antibody-drug conjugates","volume":"10","author":"Wagh","year":"2018","journal-title":"MAbs"},{"issue":"9","key":"10.1016\/j.jpba.2023.115615_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"32","key":"10.1016\/j.jpba.2023.115615_bib3","doi-asserted-by":"crossref","first-page":"53854","DOI":"10.18632\/oncotarget.17957","article-title":"Strategies targeting angiogenesis in advanced non-small cell lung cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpba.2023.115615_bib4","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2147\/OTT.S61132","article-title":"Ramucirumab: preclinical research and clinical development","volume":"7","author":"Aprile","year":"2014","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.jpba.2023.115615_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1042\/BSR20150089","article-title":"Antibody-drug conjugates as novel anti-cancer chemotherapeutics","volume":"35","author":"Peters","year":"2015","journal-title":"Biosci. Rep."},{"issue":"7","key":"10.1016\/j.jpba.2023.115615_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jlcr.3909","article-title":"Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging","volume":"64","author":"Novy","year":"2021","journal-title":"J. Label. Comp. Radio."},{"issue":"2","key":"10.1016\/j.jpba.2023.115615_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2967\/jnumed.115.166462","article-title":"PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab","volume":"57","author":"Luo","year":"2016","journal-title":"J. Nucl. Med"},{"key":"10.1016\/j.jpba.2023.115615_bib8","first-page":"166","article-title":"Bifunctional chelates for metal nuclides","volume":"52","author":"Brechbiel","year":"2008","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.jpba.2023.115615_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C3CS60304K","article-title":"Matching chelators to radiometals for radiopharmaceuticals","volume":"43","author":"Price","year":"2014","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"10.1016\/j.jpba.2023.115615_bib10","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1021\/acs.bioconjchem.1c00136","article-title":"State of the art in radiolabeling of antibodies with common and uncommon radiometals for preclinical and clinical immuno-PET","volume":"32","author":"Chomet","year":"2021","journal-title":"Bioconjug Chem."},{"key":"10.1016\/j.jpba.2023.115615_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ddtec.2018.10.002","article-title":"Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals","volume":"30","author":"Morais","year":"2018","journal-title":"Drug Discov. Today Technol."},{"issue":"6","key":"10.1016\/j.jpba.2023.115615_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4062\/biomolther.2015.116","article-title":"Strategies and advancement in antibody-drug conjugate optimization for targeted cancer therapeutics","volume":"23","author":"Kim","year":"2015","journal-title":"Biomol. Ther. (Seoul. )"},{"issue":"1","key":"10.1016\/j.jpba.2023.115615_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1124\/pr.114.009373","article-title":"Antibody drug conjugates for cancer therapy","volume":"68","author":"Polakis","year":"2016","journal-title":"Pharm. Rev."},{"issue":"6","key":"10.1016\/j.jpba.2023.115615_bib14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.nucmedbio.2004.04.004","article-title":"Development of a spectroscopic assay for bifunctional ligand-protein conjugates based on copper","volume":"31","author":"Brady","year":"2004","journal-title":"Nucl. Med Biol."},{"issue":"3","key":"10.1016\/j.jpba.2023.115615_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpha.2020.05.008","article-title":"Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugates","volume":"10","author":"Zhu","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jpba.2023.115615_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpba.2015.02.037","article-title":"Ion-exchange chromatography for the characterization of biopharmaceuticals","volume":"113","author":"Fekete","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115615_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338987","article-title":"The importance of being metal-free: the critical choice of column hardware for size exclusion chromatography coupled to high resolution mass spectrometry","volume":"1183","author":"Murisier","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2023.115615_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jchromb.2017.09.027","article-title":"Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation","volume":"1065\u20131066","author":"Goyon","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2023.115615_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jpba.2017.06.022","article-title":"Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates","volume":"147","author":"Bobaly","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115615_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpba.2017.06.016","article-title":"Analysis of recombinant monoclonal antibodies in hydrophilic interaction chromatography: a generic method development approach","volume":"145","author":"Bobaly","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115615_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jchromb.2018.02.026","article-title":"Characterization of an antibody-drug conjugate by hydrophilic interaction chromatography coupled to mass spectrometry","volume":"1080","author":"D'Atri","year":"2018","journal-title":"J. Chromatogr. B"},{"issue":"2","key":"10.1016\/j.jpba.2023.115615_bib22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.21873\/anticanres.13170","article-title":"Antiangiogenic human monoclonal antibody ramucirumab radiolabelling: in vitro evaluation on VEGFR2-positive cell lines","volume":"39","author":"Janousek","year":"2019","journal-title":"Anticancer Res"},{"issue":"15","key":"10.1016\/j.jpba.2023.115615_bib23","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1021\/acs.analchem.8b02100","article-title":"Improved LC\/MS methods for the analysis of metal-sensitive analytes using medronic acid as a mobile phase additive","volume":"90","author":"Hsiao","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2023.115615_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.chroma.2015.10.056","article-title":"Some factors that can lead to poor peak shape in hydrophilic interaction chromatography, and possibilities for their remediation","volume":"1427","author":"Heaton","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2023.115615_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.aca.2017.05.020","article-title":"Hydrophilic interaction liquid chromatography-mass spectrometry as a new tool for the characterization of intact semi-synthetic glycoproteins","volume":"981","author":"Tengattini","year":"2017","journal-title":"Anal. Chim. Acta"},{"issue":"8","key":"10.1016\/j.jpba.2023.115615_bib27","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/19420862.2018.1521128","article-title":"Evidence of disulfide bond scrambling during production of an antibody-drug conjugate","volume":"10","author":"Liu-Shin","year":"2018","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.jpba.2023.115615_bib28","first-page":"2","article-title":"Evaluation of different PNGase F enzymes in immunoglobulin G and total plasma N-glycans analysis","volume":"31","author":"Vilaj","year":"2021","journal-title":"Glycobiology"},{"issue":"19","key":"10.1016\/j.jpba.2023.115615_bib29","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00216-018-1561-1","article-title":"A generic workflow for the characterization of therapeutic monoclonal antibodies-application to daratumumab","volume":"411","author":"Duivelshof","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"10.1016\/j.jpba.2023.115615_bib30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4161\/mabs.28762","article-title":"A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization","volume":"6","author":"An","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.jpba.2023.115615_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-62703-541-5_17","article-title":"Drug-to-antibody ratio (DAR) and drug load distribution by hydrophobic interaction chromatography and reversed phase high-performance liquid chromatography","volume":"1045","author":"Ouyang","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpba.2023.115615_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122512","article-title":"Evaluation of strategies for overcoming trifluoroacetic acid ionization suppression resulted in single-column intact level, middle-up, and bottom-up reversed-phase LC-MS analyses of antibody biopharmaceuticals","volume":"233","author":"Khalikova","year":"2021","journal-title":"Talanta"},{"issue":"3","key":"10.1016\/j.jpba.2023.115615_bib33","first-page":"155","article-title":"Peptide map of monoclonal antibodies and antibody\u2013drug conjugates using micro-pillar array columns combined with mass spectrometry","volume":"31","author":"Vandenheede","year":"2018","journal-title":"LCGC Eur."},{"issue":"23","key":"10.1016\/j.jpba.2023.115615_bib34","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1039\/c0dt01595d","article-title":"A practical guide to the construction of radiometallated bioconjugates for positron emission tomography","volume":"40","author":"Zeglis","year":"2011","journal-title":"Dalton Trans."},{"issue":"3","key":"10.1016\/j.jpba.2023.115615_bib35","first-page":"423","article-title":"The reaction of allyl isothiocyanate with hydroxyl and beta-cyclodextrin using ultraviolet spectrometry","volume":"44","author":"Jiang","year":"2006","journal-title":"Food Technol. Biotechnol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:55:07Z","timestamp":1778540107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523003849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"alternative-id":["S0731708523003849"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115615","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementing reversed-phase and hydrophilic interaction liquid chromatography into the characterization of DTPA-ramucirumab conjugate before radiolabeling","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115615"}}